Placental Tissue 2.0TM
Americord is the pioneer of and only cord blood bank to offer Placental Tissue 2.0TM – because stem cell banking should benefit the whole family.
Through our patented process, Americord can collect two types of valuable stem cells from the placenta at birth: mesenchymal stem cells (MSCs), and an entirely unique and new kind of stem cell called amniotic epithelial cells (or AECs). The MSCs collected in this process are more densely-packed and, when paired with the AECs, provide a more efficient resource that opens up many new treatment opportunities.
This stem cell source is currently used to treat:
- Eye conditions that can lead to blindness
- Diabetic ulcers, which are prone to infections and can lead to amputations
- Surgical wounds, to promote faster, healthier healing
There are also advanced clinical trials for dozens of conditions that do not yet have established treatments using stem cells from cord blood or tissue, but are showing promise with treatment from Placental Tissue 2.0TM stem cells. These include:
- Cerebral palsy
- Prostate cancer
- Throat cancer
- Neurological dysfunction
- Kidney failure
- Heart conditions
- Injuries to the joints and spine
We know your first priority is the well-being of your child, but with Placental Tissue 2.0TM Americord is also committed to helping the rest of your family live healthier, longer lives. These stem cells can be used to treat your newborn, but also every other first- 0r- second-degree relative. That means mom, dad, siblings, and even grandma and grandpa can use these cells, should the need ever arise. Banking this tissue is an opportunity to give your entire family access to the future of regenerative stem cell medicine.